Company Description
Biovail Corporation. The Group's principal activities are developing, manufacturing and distributing pharmaceutical products. The Group develops generic formulations of medications for the treatment of chronic medical conditions. The services of the ...
More
Related Business Topics
Breaking News
ABC News - November 09, 2009 4:36 PM
Acadia Pharmaceuticals Inc. said Monday its third-quarter loss narrowed on lower costs and a boost in revenue from its drug development partners. The development-stage biopharmaceutical company lost $8.7 million, or 23 cents per share, compared with a ...
Forbes.com - November 05, 2009 9:50 AM
* Revenue up 17 pct at $212.5 mln * Says a number of deals in works * Shares off 1.3 percent at C$13.95 (Adds analyst and company quotes. In U.S. dollars) TORONTO (Reuters) - Biovail Corp ( BVF - news - people ) reported a lower quarterly profit ...
Reuters Canada - November 05, 2009 9:25 AM
TORONTO (Reuters) - Biovail Corp (BVF.TO: Quote) (BVF.N: Quote) reported a lower quarterly profit on Thursday, hurt by research and development costs and restructuring charges. But Canada's biggest publicly traded pharmaceutical company said that would ...
Reuters India - November 05, 2009 9:21 AM
* Shares off 1.3 percent at C$13.95 (Adds analyst and company quotes. In U.S. dollars) TORONTO, Nov 5 (Reuters) - Biovail Corp (BVF.TO: Quote, Profile, Research) (BVF.N: Quote, Profile, Research) reported a lower quarterly profit on Thursday, hurt by ...
Reuters UK - November 05, 2009 9:10 AM
* Revenue up 17 pct at $212.5 mln * Says a number of deals in works * Shares off 1.3 percent at C$13.95 (Adds analyst and company quotes. In U.S. dollars) TORONTO, Nov 5 (Reuters) - Biovail Corp (BVF.TO) (BVF.N) reported a lower quarterly profit on ...
